Autism as a disorder of neural information processing: Directions for research and targets for therapy

Molecular Psychiatry

Volumn 9, Issue 7, 2004, Pages 646-663

  Belmonte, M K ^a   Cook Jr , E H ^b   Anderson, G M ^c   Rubenstein, J L R ^d   Greenough, W T ^e   Beckel Mitchener, A ^e   Courchesne, E ^f   Boulanger, L M ^g   Powell, S B ^h   Levitt, P R ⁱ   Perry, E K ^j   Jiang, Y H ^k   DeLorey, T M ^l   Tierney, E ^m  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CHICAGO   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j NEWCASTLE UNIVERSITY   (United Kingdom)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l MOLECULAR RESEARCH INSTITUTE   (United States)

^m KENNEDY KRIEGER INSTITUTE   (United States)

more..

Author keywords

Animal models; Autism; Development; Genetics; Neurochemistry

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; LIPID; SEROTONIN;

AUTISM; BRAIN DEVELOPMENT; CLINICAL RESEARCH; DOWN SYNDROME; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC PREDISPOSITION; INFORMATION PROCESSING; NERVE CELL NETWORK; NEUROANATOMY; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROIMAGING; NEUROPHYSIOLOGY; NEUROPSYCHIATRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO; SMITH LEMLI OPITZ SYNDROME;

EID: 3042775209     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001499     Document Type: Review

References (200)

1. Frith U. Autism: Explaining the Enigma. Blackwell: Oxford, 1989.
2. Ozonoff S, Pennington B, Rogers SJ. Executive function deficits in high-functioning autistic individuals: relationship to theory of mind. J Child Psychol Psychiatry 1991; 32: 1081-1105.
3. Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a 'theory of mind'? Cognition 1985; 21: 37-46.
4. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002; 6: 248-254.
5. Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M et al. Development of the brainstem and cerebellum in autistic patients. J Autism Devel Disord 1995; 25: 1-18.
6. Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology 1999; 53: 2145-2150.
7. Courchesne E, Karns C, Davis HR, Ziccardi R, Carper RA, Tigue ZD et al. Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 2001; 57: 245-254.
8. Sparks BF, Friedman SD, Shaw DW, Aylward EH, Echelard D, Artru AA et al. Brain structural abnormalities in young children with autism spectrum disorder. Neurology 2002; 59: 184-192.
9. Aylward EH, Minshew NJ, Field K, Sparks BF, Singh N. Effects of age on brain volume and head circumference in autism. Neurology 2002; 59: 175-183.
10. Johnson MH, Halit H, Grice SJ, Karmiloff-Smith A. Neuroimaging of typical and atypical development: a perspective from multiple levels of analysis. Dev Psychopathol 2002; 14: 521-536.
11. Rubia K. The dynamic approach to neurodevelopmental psychiatric disorders: use of fMRI combined with neuropsychology to elucidate the dynamics of psychiatric disorders, exemplified in ADHD and schizophrenia. Behav Brain Res 2002; 130: 47-56.
12. Courchesne E, Chisum H, Townsend J. Neural activity-dependent brain changes in development: implications for psychopathology. Dev Psychopathol 1994; 6: 697-722.
13. Akshoomoff N, Pierce K, Courchesne E. The neurobiological basis of autism from a developmental perspective. Dev Psychopathol 2002; 14: 613-634.
14. Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2001; 2: 943-955.
15. Ballaban-Gil K, Tuchman R. Epilepsy and epileptiform EEG: association with autism and language disorders. Ment Retard Dev Disabil Res Rev 2000; 6: 300-308.
16. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL (eds). The Neurobiology of Autism. Johns Hopkins University Press: Baltimore, MD, 1994 pp. 119-145.
17. Raymond G, Bauman M, Kemper T. Hippocampus in autism: a Golgi analysis. Acta Neuropathol 1996; 91: 117-119.
18. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in autism. Neurology 2002; 58: 428-432.
19. Cohen I. An artificial neural network analogue of learning in autism. Biol Psychiatry 1994; 36: 5-20.
20. Belmonte MK, Yurgelun-Todd DA. Functional anatomy of impaired selective attention and compensatory processing in autism. Cogn Brain Res 2003; 17: 651-664.
21. Tordjman S, Anderson GM, McBride PA, Hertzig ME, Snow ME, Hall LM et al. Plasma β-endorphin, adrenocorticotropin hormone, and cortisol in autism. J Child Psychol Psychiatry 1997; 38: 705-715.
22. Hirstein W, Iversen P, Ramachandran VS. Autonomic responses of autistic children to people and objects. Proc R Soc Land B 2001; 268: 1883-1888.
23. Ring HA, Baron-Cohen S, Wheelwright S, Williams SCR, Brammer MJ, Andrew C et al. Cerebral correlates of preserved cognitive skills in autism. Brain 1999; 122: 1305-1315.
24. Critchley HD, Daly EM, Bullmore ET, Williams SCR, Van Amelsvoort T, Robertson DM et al. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain 2000; 123: 2203-2212.
25. Schultz RT, Gauthier I, Klin A, Fulbright RK, Anderson AW, Volkmar F et al. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry 2000; 57: 331-340.
26. Pierce K, Müller R-A, Ambrose J, Allen G, Courchesne E. Face processing occurs outside the fusiform 'face area' in autism: evidence from functional MRI. Brain 2001; 124: 2059-2073.
27. Baron-Cohen S, Ring HA, Wheelwright S, Bullmore ET, Brammer MJ, Simmons A et al. Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci 1999; 11: 1891-1898.
28. Castelli F, Frith C, Happé F, Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain 2002; 125: 1839-1849.
29. Townsend J, Courchesne E. Parietal damage and narrow 'spotlight' spatial attention. J Cogn Neurosci 1994; 6: 220-232.
30. Belmonte MK. Abnormal attention in autism shown by steadystate visual evoked potentials. Autism 2000; 4: 269-285.
31. Kemner C, Verbaten MN, Cuperus JM, Camfferman G, van Engeland H. Visual and somatosensory event-related brain potentials in autistic children and three different control groups. EEG Clin Neurophysiol 1994; 92: 225-237.
32. Kemner C, Verbaten MN, Cuperus JM, Camfferman G, van Engeland H. Auditory event-related brain potentials in autistic children and three different control groups. Biol Psychiatry 1995; 38: 150-165.
33. Burack JA, Enns JT, Stauder JEA, Mottron L, Randolph B. Attention and autism: behavioral and electrophysiological evidence. In: Cohen DJ, Volkmar FR (eds). Handbook of Autism and Pervasive Developmental Disorders, 2nd edn. Wiley: New York, 1997 pp 226-247.
34. Courchesne E, Townsend J, Akshoomoff N, Saitoh O, Yeung-Courchesne R, Lincoln AJ et al. Impairment in shifting attention in autistic and cerebellar patients. Behav Neurosci 1994; 108: 848-865.
35. Townsend J, Courchesne E, Covington J, Westerfield M, Harris NS, Lyden P et al. Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J Neurosci 1999; 19: 5632-5643.
36. Courchesne E, Townsend J, Akshoomoff N, Yeung-Courchesne R, Lincoln AJ, Press G et al. A new finding: impairment in shifting attention in autistic and cerebellar patients. In: Broman SH, Grafman J (eds). Atypical Cognitive Deficits in Developmental Disorders: Implications for Brain Function. Lawrence Erlbaum: Hillsdale, NJ, 1994 pp 101-137.
37. Courchesne E, Lincoln AJ, Yeung-Courchesne R, Elmasian R, Grillon C. Pathophysiologic findings in nonretarded autism and receptive developmental language disorder. J Autism Dev Disord 1989; 19: 1-17.
38. Townsend J, Westerfield M, Leaver E, Makeig S, Jung T, Pierce K et al. Event-related brain response abnormalities in autism: evidence for impaired cerebello-frontal spatial attention networks. Cogn Brain Res 2001; 11: 127-145.
39. Müller R-A, Kleinhans N, Kemmotsu N, Pierce K, Courchesne E. Abnormal variability and distribution of functional maps in autism: an fMRI study of visuomotor learning. Am J Psychiatry 2003; 160: 1847-1862.
40. Shah A, Frith U. An islet of ability in autistic children: a research note. J Child Psychol Psychiatry 1983; 24: 613-620.
41. Shah A, Frith U. Why do autistic individuals show superior performance on the block design task? J Child Psychol Psychiatry 1993; 34: 1351-1364.
42. Whitehouse D, Harris JC. Hyperlexia in infantile autism. J Autism Dev Disord 1984; 14: 281-289.
43. Boucher J, Lewis V. Unfamiliar face recognition in relatively able autistic children. J Child Psychol Psychiatry 1992; 33: 843-859.
44. Klin A, Sparrow SS, de Bildt A, Cicchetti DV, Cohen DJ, Volkmar FR. A normed study of face recognition in autism and related disorders. J Autism Dev Disord 1999; 29: 499-508.
45. Hobson RP, Ouston J, Lee A. What's in a face? The case of autism. Br J Psychol 1988; 79: 441-453.
46. Tantam D, Monaghan L, Nicholson H, Stirling J. Autistic children's ability to interpret faces: a research note. J Child Psychol Psychiatry 1989; 30: 623-630.
47. Toichi M, Kamio Y. Long-term memory and levels-of-processing in autism. Neuropsychologia 2002; 40: 964-969.
48. Plaisted KG, Swettenham J, Rees L. Children with autism show local precedence in a divided attention task and global precedence in a selective attention task. J Child Psychol Psychiatry 1999; 40: 733-742.
49. Plaisted KC, Saksida L, Alcántara J, Weisblatt E. Towards an understanding of the mechanisms of weak central coherence effects: experiments in visual configural learning and auditory perception. Phil Trans R Soc Land B 2003; 358: 375-386.
50. Mottron L, Burack JA. Enhanced perceptual functioning in the development of autism. In: Burack JA, Charman T, Yirmiya N, Zelazo PR (eds). The Development of Autism: Perspectives from Theory and Research. Lawrence Erlbaum Associates: Mahwah, NJ, 2001.
51. Frith U, Happé F. Autism: beyond 'theory of mind'. Cognition 1994; 50: 115-132.
52. Russell J, Saltmarsh R, Hill E. What do executive factors contribute to the failure on false belief tasks by children with autism? J Child Psychol Psychiatry 1999; 40: 859-868.
53. Klin A, Volkmar FR, Sparrow SS. Autistic social dysfunction: some limitations of the theory of mind hypothesis. J Child Psychol Psychiatry 1992; 33: 861-876.
54. Rogers SJ, Pennington BF. A theoretical approach to the deficits in infantile autism. Dev Psychopathol 1991; 3: 137-162.
55. Frith U. Mind blindness and the brain in autism. Neuron 2001; 32: 969-979.
56. Courchesne E. Abnormal early brain development in autism. Mol Psychiatry 2002; 7: S21-23.
57. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003; 290: 337-344.
58. Herbert MR, Ziegler DA, Makris N, Filipek PA, Kemper TL, Normandin JJ et al. Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 2004; 55. (in press).
59. Carper RA, Moses P, Tigue ZD, Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. NeuroImage 2002; 16: 1038-1051.
60. Yakovlev PI, Lecours A-R. The myelogenetic cycles of regional maturation of the brain. In: Minkowski A (ed). Regional Development of the Brain in Early Life. Blackwell: Oxford, 1967 pp 3-65.
61. Belmonte MK, Egaas B, Townsend J, Courchesne E. NMR intensity of corpus callosum differs with age but not with diagnosis of autism. Neuroreport 1995; 6: 1253-1256.
62. Powell EM, Campbell DB, Stanwood GD, Davis C, Noebels JL, Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 2003; 23: 622-631.
63. Jorde L, Hasstedt S, Ritvo E, Mason-Brothers A, Freeman B, Pingree C et al. Complex segregation analysis of autism. Am J Hum Genet 1991; 49: 932-938.
64. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001; 285: 3093-3099.
65. Pickles A, Bolton P, Macdonald H, Bailey A, Le Couteur A, Sim CH et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet 1995; 57: 717-726.
66. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 493-507.
67. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124-137.
68. Lauritsen M, Ewald H. The genetics of autism. Acta Psychiatr Scand 2001; 103: 411-427.
69. Lamb JA, Parr JR, Bailey AJ, Monaco AP. Autism: in search of susceptibility genes. Neuromol Med 2002; 2: 11-28.
70. Cook Jr EH. Genetics of autism. In: Cooper D (ed). Nature Encyclopedia of the Human Genome. Nature Publishing Group: London, 2003.
71. Geschwind DH, Sowinski J, Lord C, Iversen P, Shestack J, Jones P et al. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Am J Hum Genet 2001; 69: 463-466.
72. Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg IC et al. Paris Autism Research International Sibpair Study. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27-29.
73. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-188.
74. Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 2003; 28: 205-211.
75. Bailey Jr DB, Hatton DD, Skinner M, Mesibov G. Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome. J Autism Dev Disord 2001; 31: 165-174.
76. Wassink TH, Piven J, Patil SR. Chromosomal abnormalities in a clinic sample of individuals with autistic disorder. Psychiatr Genet 2001; 11: 57-63.
77. Cohen, IL, Vietze PM, Sudhalter V, Jenkins EC, Brown WT. Effects of age and communication level on eye contact in fragile X males and non-fragile X autistic males. Am J Med Genet 1991; 38: 498-502.
78. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991; 23: 817-822.
79. Ashley Jr CT, Wilkinson KD, Reines D, Warren ST. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 1993; 262: 563-566.
80. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, Liu L et al. RNA cargoes associating with FMRP reveal deficits in cellular functioning in FMR1 null mice. Neuron 2003; 37: 417-431.
81. Weiler IJ, Irwin SA, Klintsova AY, Spencer CM, Brazelton AD, Miyashiro K et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 1997; 94: 5395-5400.
82. Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ. Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci USA 2001; 98: 7101-7106.
83. Irwin SA, Swain RA, Christmon CA, Chakravarti A, Weiler IJ, Greenough WT. Evidence for altered fragile-X mental retardation protein expression in response to behavioral stimulation. Neurobiol Learn Mem 2000; 73: 87-93.
84. Todd PK, Mack KJ. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo. Mol Brain Res 2000; 80: 17-25.
85. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 1997; 94: 5401-5404.
86. Galvez R, Gopal AR, Greenough WT. Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome. Brain Res 2003; 971: 83-89.
87. Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 2001; 98: 161-167.
88. Jiang YH, Tsai TF, Bressler J, Beaudet AL. Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev 1998; 8: 334-342.
89. Beaudet AL. Is medical genetics neglecting epigenetics? Genet Med 2002; 4: 399-402.
90. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001; 293: 1089-1093.
91. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 1998; 21: 799-811.
92. Yu Y, Bradley A. Engineering chromosomal rearrangements in mice. Nat Rev Genet 2001; 2: 780-790.
93. DeFelipe J, Hendry SH, Hashikawa T, Molinari M, Jones EG. A microcolumnar structure of monkey cerebral cortex revealed by immunocytochemical studies of double bouquet cell axons. Neuroscience 1990; 23: 622-631.
94. Peters A, Sethares C. The organization of double bouquet cells in monkey striate cortex. J Neurocytol 1997; 26: 779-797.
95. Anderson S, Qiu M, Bulfone A, Eisenstat D, Meneses JJ, Pedersen RA et al. Mutations of the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal subventricular zone and differentiation of late-born striatal cells. Neuron 1997; 19: 27-37.
96. Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 2001; 31: 537-543.
97. Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H. Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 1993; 87: 312-316.
98. Rubenstein JLR, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2003; 2: 255-267.
99. Hensch TK, Fagiolini M, Malaga N, Stryker MP, Baekkeskov S, Kash SF. Local GABA circuit control of experience-dependent plasticity in the developing visual cortex. Science 1998; 282: 1504-1508.
100. Marin O, Rubenstein JLR. A long, remarkable journey: cellular and molecular mechanisms of tangential migration in the telencephalon. Nat Neurosci Rev 2001; 2: 780-790.
101. IMGSAC. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001; 69: 570-581.
102. Stühmer T, Anderson SA, Ekker M, Rubenstein JLR. Ectopic expression of the Dlx genes induces glutamic acid decarboxylase and Dlx expression. Development 2002; 129: 245-252.
103. Stühmer T, Puelles L, Ekker M, Rubenstein JLR. Expression from a Dlx gene enhancer marks adult mouse cortical GABAergic neurons. Cereb Cortex 2002; 12: 75-85.
104. Long JE, Garel S, Depew M, Tobet S, Rubenstein JLR. DLX5 regulates development of peripheral and central components of the olfactory system. J Neurosci 2003; 23: 568-578.
105. Alcantara S, Ruiz M, D'Arcangelo G, Ezan F, de Lecea L, Curran T et al. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J Neurosci 1998; 18: 7779-7799.
106. A receptor subunit mRNAs in the brain. III. Embryonic and postnatal development. J Neurosci 1992; 12: 4151-4172.
107. A receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome. J Neurosci 1998; 18: 8505-8514.
108. 3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci USA 1997; 94: 4143-4148.
109. A receptor. Neuroscience 2000; 95: 795-806.
110. A receptor. Brain Res 2002; 955: 221-228.
111. Mirza NR, Stolerman IP. The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology 2000; 148: 243-250.
112. Kimura F. Cholinergic modulation of cortical function: a hypothetical role in shifting the dynamics in cortical network. Neurosci Res 2000; 38: 19-26.
113. Marubio LM, del Mar Arroyo- Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove d'Exaerde A et al. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 1999; 398: 805-810.
114. Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 2002; 13: 1097-1106.
115. Court JA, Martin-Ruiz C, Graham A, Perry E. Nicotinic receptors in human brain: topography and pathology. J Chem Neuroanat 2000; 20: 281-298.
116. Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M et al. Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol 2000; 393: 215-222.
117. Lee M, Martin-Ruiz C, Graham A, Court J, Jaros E, Perry R et al. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 2002; 125: 1483-1495.
118. 2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus. J Neurophysiol 2001; 86: 3043-3055.
119. Hohmann CF, Berger-Sweeney J. Cholinergic regulation of cortical development and plasticity. New twists to an old story. Perspect Dev Neurobiol 1998; 5: 401-425.
120. Ward NL, Hagg T. BDNF is needed for postnatal maturation of basal forebrain and neostriatum cholinergic neurons in vivo. Exp Neurol 2000; 162: 297-310.
121. Hardan AY, Handen BL. A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 2002; 12: 237-241.
122. Schain RJ, Freedman DX. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961; 58: 315-320.
123. Whitaker-Azmitia PM. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001; 56: 479-485.
124. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998; 44: 151-162.
125. Posey DJ, McDougle CJ. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harvard Rev Psychiatry 2000; 8: 45-63.
126. Cook Jr EH, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr 1996; 8: 348-354.
127. Anderson GM, Gutknecht L, Cohen DJ, Brailly-Tabard S, Cohen JH, Ferrari P et al. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 2002; 7: 831-836.
128. Veenstra-VanderWeele J, Anderson GM, Cook Jr EH. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol 2000; 410: 165-181.
129. Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N et al. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 2002; 7: 278-288.
130. Tordjman S, Gutneckt L, Carlier M, Spitz E, Antoine C, Slama F et al. Role of the serotonin transporter in the behavioral expression of autism. Mol Psychiatry 2001; 6: 434-439.
131. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD et al. Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet 2004; doi:10.1002/ajmg.b. 20151.
132. Smith DW, Lemli L, Opitz JM. A newly recognized syndrome of multiple congenital anomalies. J Pediatr 1964; 64: 210-217.
133. Kelley RI, Hennekam RCH. Smith-Lemli-Opitz Syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D. (eds) The Metabolic and Molecular Basis of Inherited Disease, 8th edn. McGraw-Hill: New York, 2000.
134. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994; 330: 107-113.
135. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview - Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994; 24: 659-685.
136. Tierney E, Nwokoro NA, Porter FD, Freund LS, Ghuman JK, Kelly RI. The behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet 2001; 98: 191-200.
137. 1 with autism. J Neuroimmunol 1996; 67: 97-102.
138. Rogers T, Kalaydjieva L, Hallmayer J, Peterson PB, Nicholas P, Pingree C et al. Exclusion of linkage to the HLA region in ninety multiplex sibships with autism. J Autism Dev Disord 1999; 29: 195-201.
139. Warren RP, Burger RA, Odell D, Torres AR, Warren WL. Decreased plasma concentrations of the C4B complement protein in autism. Arch Pediatr Adolesc Med 1994; 148: 180-183.
140. Krause I, He X-S, Gershwin ME, Shoenfeld Y. Immune factors in autism: a critical review. J Autism Devel Disord 2002; 32: 337-345.
141. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurological disorders. J Pediatrics 1999; 134: 607-613.
142. Denney DR, Frei BW, Gaffney GR. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord 1996; 26: 87-97.
143. Warren RP, Foster A, Margaretten NC. Reduced natural killer cell activity in autism. J Amer Acad Child Adolesc Psychiatry 1987; 26: 333-335.
144. Gupta S, Aggarwal S, Rashanravan B, Lee T. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998; 85: 106-109.
145. Hugdahl K, Synnevag B, Satz P. Immune and autoimmune diseases in dyslexic children. Neuropsychologia 1990; 28: 673-679.
146. Cardon LR, Smith SD, Fulker DW, Kimberling WJ, Pennington BF, DeFries JC. Quantitative trait locus for reading disability on chromosome 6. Science 1994; 266: 276-279.
147. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 1999; 14: 388-394.
148. Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 1993; 80: 395-400.
149. Fatemi SH, Earle J, Kanodia R, Kist D, Emamian ES, Patterson PH et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002; 22: 25-33.
150. Shi L, Fatemi SH, Sidwell RW, Patterson PH. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003; 23: 297-302.
151. Patterson PH. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002; 12: 115-118.
152. Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ. Functional requirement for class IMHC in CNS development and plasticity. Science 2000; 290: 2155-2159.
153. Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 2003; 53: 533-537.
154. Corriveau RA, Huh GS, Shatz CJ. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 1998; 21: 505-520.
155. Boulanger LM, Huh GS, Shatz CJ. Neuronal plasticity and cellular immunity: shared molecular mechanisms. Curr Opin Neurobiol 2001; 11: 568-578.
156. Machado CJ, Bachevalier J. Non-human primate models of childhood psychopathology: the promise and the limitations. J Child Psychol Psychiatry 2003; 44: 64-87.
157. Geyer MA, Markou A. Animal models of psychiatric disorders. In: Bloom FE, Kupfer D (eds). Psychopharmacology: The Fourth Generation of Progress. Raven Press: New York, 1995 pp 787-798.
158. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000; 23: 223-239.
159. Graham F. The more or less startling effects of weak prestimulation. Psychophysiology 1975; 12: 238-248.
160. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001; 156: 234-258.
161. Geyer MA, Kiebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001; 156: 117-154.
162. Swerdlow NR, Geyer MA, Braff DL. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001; 156: 194-215.
163. Swerdlow NR, Braff DL, Taaid N, Geyer MA. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry 1994; 51: 139-154.
164. Ornitz EM, Lane SJ, Sugiyama T, de Traversay J. Startle modulation studies in autism. J Autism Dev Disord 1993; 23: 619-637.
165. McAlonan GM, Daly E, Kumari V, Critchley HD, van Amelsvoort T, Suckling J et al. Brain anatomy and sensorimotor gating in Asperger's syndrome. Brain 2002; 125: 1594-1606.
166. Stevens S, Gruzelier J. Electrodermal activity to auditory stimuli in autistic, retarded, and normal children. J Autism Dev Disord 1984; 14: 245-260.
167. van Engeland H. The electrodermal orienting response to auditive stimuli in autistic children, normal children, mentally retarded children, and child psychiatric patients. J Autism Dev Disord 1984; 14: 261-279.
168. Belser RC, Sudhalter V. Arousal difficulties in males with fragile X syndrome: a preliminary report. Dev Brain Dysfunct 1995; 8: 270-279.
169. Miller LJ, McIntosh DN, McGrath J, Shyu V, Lampe M, Taylor AK et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 1999; 83: 268-279.
170. Powell SB, Geyer, MA. Developmental markers of psychiatric disorders as identified by sensorimotor gating. Neurotoxic Res 2002; 4: 489-502.
171. Pletnikov MV, Rubin SA, Vasudevan K, Moran TH, Carbone KM. Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav Brain Res 1999; 100: 43-50.
172. Ingram JL, Peckham SM, Tisdale B, Rodier PM. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxic Teratol 2000; 22: 319-324.
173. Caston J, Yon E, Mellier D, Godfrey HP, Delhaye-Bouchard N, Mariani J. An animal model of autism: behavioural studies in the GS guinea pig. Eur J Neurosci 1998; 10: 2677-2684.
174. Kuwamura M, Morikawa T, Yamate J, Kato K, Kotani T, Sakuma S. Glial pathology in development of cerebellar dysplasia in the hereditary cerebellar vermis defect (cvd) rat. Acta Neuropathol 2000; 99: 305-309.
175. Bobee S, Mariette E, Tremblay-Leveau H, Caston J. Effects of early midline cerebellar lesion on cognitive and emotional functions in the rat. Behav Brain Res 2000; 112: 107-117.
176. Tueting P, Costa E, Dwivedi Y, Guidotti A, Impagnatiello F, Manev R et al. The phenotypic characteristics of heterozygous reeler mouse. Neuroreport 1999; 10: 1329-1334.
177. Park C, Falls W, Finger JH, Longo-Guess CM, Ackerman SL. Deletion in Catna2, encoding αN-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation. Nat Genet 2002; 31: 279-284.
178. Chang EF, Merzenich MM. Environmental noise retards auditory cortical development. Science 2003; 300: 498-502.
179. Pierce K, Courchesne E. Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry 2001; 49: 655-664.
180. Lalonde R, Manseau M, Boetz MI. Exploration and habituation in Purkinje cell degeneration mutant mice. Brain Res 1989; 479: 201-203.
181. Kamiguchi H, Hlavin ML, Lemmon V. Role of L1 in neural development: what the knockouts tell us. Mol Cell Neurosci 1998; 12: 48-55.
182. Fransen E, D'Hooge R, Van Camp G, Verhoye M, Sijbers J, Reyniers E et al. L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired
183. Leaton RN, Supple Jr WF. Medial cerebellum and long-term habituation of acoustic startle in rats. Behav Neurosci 1991; 105: 804-816.
184. Silverman JM, Smith CJ, Schmeidler J, Hollander E, Lawlor BA, Fitzgerald M et al. Symptom domains in autism and related conditions: evidence for familiality. Am J Med Genet 2002; 114: 64-73.
185. Hughes C, Plumet MH, Leboyer M. Towards a cognitive phenotype for autism: increased prevalence of executive dysfunction and superior spatial span amongst siblings of children with autism. J Child Psychol Psychiatry 1999; 40: 705-718.
186. Baron-Cohen S, Hammer J. Parents of children with Asperger syndrome: what is the cognitive phenotype? J Cogn Neurosci 1997; 9: 548-554.
187. O'Riordan MA, Plaisted KG, Driver J, Baron-Cohen S. Superior visual search in autism. J Exp Psychol Hum Percept Perform 2001; 27: 719-730.
188. Happ F, Briskman J, Frith U. Exploring the cognitive phenotype of autism: weak 'central coherence' in parents and siblings of children with autism: I. Experimental tests. J Child Psychol Psychiatry 2001; 42: 299-307.
189. Folstein SE, Gilman SE, Landa R, Hein J, Santangelo SL, Piven J et al. Predictors of cognitive test patterns in autism families. J Child Psychol Psychiatry 1999; 40: 1117-1128.
190. Hughes C, Leboyer M, Bouvard M. Executive function in parents of children with autism. Psychol Med 1997; 27: 209-220.
191. Piven J, Palmer P, Landa R, Santangelo S, Jacobi D, Childress D. Personality and language characteristics in parents from multiple-incidence autism families. Am J Med Genet 1997; 74: 398-411.
192. Fombonne E, Bolton P, Prior J, Jordan H, Rutter M. A family study of autism: cognitive patterns and levels in parents and siblings. J Child Psychol Psychiatry 1997; 38: 667-683.
193. Piven J, Palmer P. Cognitive deficits in parents from multiple-incidence autism families. J Child Psychol Psychiatry 1994; 38: 1011-1021.
194. Baron-Cohen S, Wheelwright S, Stott C, Bolton P, Goodyer I. Is there a link between engineering and autism? Autism 1997; 1: 153-163.
195. Baron-Cohen S, Bolton P, Wheelwright S, Scahill V, Short L, Mead G et al. Autism occurs more often in families of physicists, engineers, and mathematicians. Autism 1998; 2: 296-301.
196. Piven J, Gayle J, Chase GA, Fink B, Landa R, Wzorek MM et al. A family history study of neuropsychiatric disorders in the adult siblings of autistic individuals. J Am Acad Child Adolesc Psychiatry 1990; 29: 177-183.
197. DeLong R, Nohria C. Psychiatric family history and neurological disease in autistic spectrum disorders. Dev Med Child Neurol 1994; 36: 441-448.
198. Baranek GT. Autism during infancy: a retrospective video analysis of sensory-motor and social behaviors at 9-12 months of age. J Autism Dev Disord 1999; 29: 213-224.
199. Hallett M, Lebiedowska MK, Thomas SL, Stanhope SJ, Denckla MB, Rumsey J. Locomotion of autistic adults. Arch Neurol 1993; 50: 1304-1308.
200. Smith IM. Motor functioning in Asperger's syndrome. In: Klin A, Volkmar FR, Sparrow SS (eds). Asperger's Syndrome. The Guildford Press: New York, 2000.